Table 1.
Author | Year | circRNAs profiles | Cancer type |
Specimen | Test method | Sample size (case/control) |
Sensitivity | Specificity |
---|---|---|---|---|---|---|---|---|
Li et al.8 | 2017 | hsa_circ_0000096 | GC | Tissues | qRT–PCR | 101/101 | 0.880 | 0.560 |
Zhu et al.9 | 2017 | hsa_circ_0013958 | LAC | Tissues | qRT–PCR | 49/49 | 0.755 | 0.796 |
hsa_circ_0013958 | LAC | Plasma | qRT–PCR | 30/30 | 0.667 | 0.933 | ||
Yin et al.10 | 2017 | hsa_circ_0001785 | BC | Plasma | qRT–PCR | 20/20 | 0.786 | 0.756 |
hsa_circ_0108942 | BC | Plasma | qRT–PCR | 20/20 | 0.815 | 0.504 | ||
hsa_circ_0068033 | BC | Plasma | qRT–PCR | 20/20 | 0.732 | 0.578 | ||
Zhao et al.11 | 2017 | hsa_circ_0000181 | GC | Tissues | qRT–PCR | 115/115 | 0.539 | 0.852 |
hsa_circ_0000181 | GC | Plasma | qRT–PCR | 102/105 | 0.990 | 0.206 | ||
Fu et al.12 | 2017 | hsa_circ_0003570 | HCC | Tissues | qRT–PCR | 107/107 | 0.449 | 0.868 |
Li et al.13 | 2017 | hsa circ 0001649 | GC | Tissues | qRT–PCR | 76/76 | 0.711 | 0.816 |
Qin et al.14 | 2015 | hsa_circ_0001649 | HCC | Tissues | qRT–PCR | 89/89 | 0.810 | 0.690 |
Wang et al.15 | 2015 | hsa_circ_001988 | CRC | Tissues | qRT–PCR | 31/31 | 0.680 | 0.730 |
Yao et al.16 | 2017 | circZKSCAN1 | HCC | Tissues | qRT–PCR | 102/102 | 0.822 | 0.724 |
Zhuo et al.17 | 2017 | circRNA0003906 | CRC | Tissues | qRT–PCR | 122/40 | 0.725 | 0.803 |
Li et al.18 | 2017 | hsa_circ_0001017 | GC | Plasma | qRT–PCR | 121/121 | 0.974 | 0.811 |
hsa_circ_0061276 | GC | Plasma | qRT–PCR | 121/121 | 0.903 | 0.517 | ||
Shang et al.19 | 2016 | hsa_circ_0005075 | HCC | Tissues | qRT–PCR | 30/30 | 0.833 | 0.900 |
Li et al.20 | 2015 | hsa_circ_002059 | GC | Tissues | qRT–PCR | 101/101 | 0.810 | 0.620 |
Chen et al.21 | 2017 | hsa_circ_0000190 | GC | Tissues | qRT–PCR | 104/104 | 0.721 | 0.683 |
hsa_circ_0000190 | GC | Plasma | qRT–PCR | 104/104 | 0.414 | 0.875 | ||
Huang et al.22 | 2017 | hsa_circ_0000745 | GC | Plasma | qRT–PCR | 60/60 | 0.855 | 0.450 |
Lu et al.23 | 2017 | hsa_circ_0006633 | GC | Tissues | qRT–PCR | 96/96 | 0.600 | 0.810 |
Sun et al.24 | 2017 | hsa_circ_0000520 | GC | Tissues | qRT–PCR | 56/56 | 0.536 | 0.857 |
hsa_circ_0000521 | GC | Plasma | qRT–PCR | 45/17 | 0.824 | 0.844 | ||
Tian et al.25 | 2017 | hsa_circ_0003159 | GC | Tissues | qRT–PCR | 108/108 | 0.852 | 0.565 |
Lu et al.26 | 2018 | hsa_circ_0000467 | GC | Plasma | qRT–PCR | 20/20 | 0.705 | 0.648 |
Zhang et al.27 | 2018 | hsa_circ_0091579 | HCC | Tissues | qRT–PCR | 30/30 | 0.970 | 0.400 |
hsa_circ_16245-1 | HCC | Tissues | qRT–PCR | 30/30 | 0.830 | 0.630 | ||
Shao et al.28 | 2017 | hsa_circ_0001895 | GC | Tissues | qRT–PCR | 96/96 | 0.678 | 0.857 |
Wang et al.29 | 2017 | hsa_circ_0000567 | CRC | Tissues | qRT–PCR | 102/102 | 0.833 | 0.765 |
Zhao et al.30 | 2018 | hsa_circ_0081001 | OSCC | Salivary | qRT–PCR | 90/82 | 0.744 | 0.902 |
Fu,et al.31 | 2017 | hsa_circ_0004018 | HCC | Tissues | qRT–PCR | 102/102 | 0.716 | 0.815 |
Abbreviations: GC, gastric cancer; BC, breast cancer; HCC, hepatocellular carcinoma; CRC, colorectal cancer; LAC, lung adenocarcinoma; OSCC, oral squamous cell carcinoma; qRT-PCR, quantitative reverse transcription PCR.